Over the past five years, Jazz Pharmaceuticals has grown an average of 175% a year.
Identity theft protection is a growing business and that's Lifelock's bread and butter.
If this company can stay on its current trajectory it has nearly 92% upside potential.
This generic drug maker is just what the investor ordered.
This quiet, industrial worker bee may not be in a popular sector but it makes money.
This company continues to prove it can deliver for shareholders.
Pharma stocks are hot and this one could be the next Pfizer.
This 'junk yard' stock is a $10 billion large-cap company and it's doing very well, thank you.
This stock isn't for widows and orphans. It's for an aggressive portfolio.
This stock has yet to turn a profit but it's already a winner for Bill Gunderson.